Penumbra
PEN · NYSE
Bulios Fair Price
$182.13
43.0% downside
Current Price
$319.39
According to Bulios Fair Price, PEN is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Solventum Corporation is an American technology company that focuses on developing innovative solutions in the fields of chemistry and pharmaceuticals. It specializes in providing services related to research, development, and commercialization of chemical and pharmaceutical products. Solventum Corporation collaborates with pharmaceutical and biotechnology companies to optimize manufacturing processes and develop new active ingredients. The company's goal is to improve the efficiency and safety of chemical processes, with a focus on sustainability and technological innovations.
Sector
Healthcare
Industry
Medical - Devices
CEO
Adam Elsesser
Employees
4,700
Headquarters
Alameda
Upcoming events
Earnings
Upcoming earnings report